Stocks and InvestingStocks and Investing
Wed, January 12, 2022
Tue, January 11, 2022
Mon, January 10, 2022
Sun, January 9, 2022
Fri, January 7, 2022

Drew Ranieri Maintained (AVNS) at Sell with Decreased Target to $36 on, Jan 7th, 2022


Published on 2024-10-27 19:11:22 - WOPRAI, Drew Ranieri
  Print publication without navigation


Drew Ranieri of Morgan Stanley, Maintained "Avanos Medical, Inc." (AVNS) at Sell with Decreased Target from $37 to $36 on, Jan 7th, 2022.

Drew, nor any peers, have made any analyst calls on AVNS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30